# Adrenal Artery Ablation for Primary Aldosteronism

> **NCT03653845** · PHASE3 · UNKNOWN · sponsor: **Third Military Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Primary Aldosteronism
- Hypertension

## Interventions

- **PROCEDURE:** Endovascular chemical Ablation of Adrenal Gland
- **DRUG:** Sequenced antihypertensvie drugs with titrated dosage

## Key facts

- **NCT ID:** NCT03653845
- **Lead sponsor:** Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03653845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03653845, "Adrenal Artery Ablation for Primary Aldosteronism". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT03653845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*